You are here:

NICE
NICE Guidance
Conditions and diseases
Mental health, behavioural and neurodevelopmental conditions
Psychosis and schizophrenia

Psychosis and schizophrenia Products

A list of all our products on psychosis and schizophrenia

Filter

Product type

Product typeGuidanceQuality standardsAdvice

Guidance programme

Guidance programmeNICE guidelinesTechnology appraisal guidanceHealth technology evaluationInterventional procedures guidance

Status
1 selected

StatusPublishedIn developmentAwaiting development

New and updated

New and updatedNew in the last 6 months

Showing 2 products

Sort by: Date | Sort by Title

Status: Awaiting developmentRemove ‘Status: Awaiting development’ filter

Abilify MyCite for treating bipolar disorder 1 or schizophrenia [ID3833]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Iclepertin for treating cognitive impairment associated with schizophrenia ID6483
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC